Conceptus, Inc. (NASDAQ: CPTS) announced the approval of its third generation Essure(R) permanent birth control system by Health Canada. System modifications include changes to the delivery system that reduce the number of steps a physician is required to perform during a placement procedure. In addition to the enhanced ease-of-use, hysteroscopic visualization of the implant and placement markers was significantly improved. [click link for full article]

More: continued here

This entry was posted on Saturday, December 15th, 2007 at 9:12 am and is filed under Fertility. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.